APO Research
Talk to an analyst

APO RESEARCH · REPORT

Prostate Cancer Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Prostate Cancer Drugs Industry Growth and Trends Forecast to 2032

20 December 2025126 pages

Choose your research edition.

Industry ResearchProstate Cancer Drugs Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Prostate Cancer Drugs Industry Growth and Trends Forecast to 2032126 pages · $3,450 USDMarket StructureGlobal Prostate Cancer Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prostate Cancer Drugs Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Prostate Cancer Drugs Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global Prostate Cancer Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Prostate Cancer Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Prostate Cancer Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Prostate Cancer Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Prostate Cancer Drugs include Takeda Pharmaceuticals, Teva Pharmaceutical, Sanofi, Johnson & Johnson, Novartis, Merck Group, GlaxoSmithKline, Amgen and AbbVie, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Prostate Cancer Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Prostate Cancer Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Prostate Cancer Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Prostate Cancer Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Prostate Cancer Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Prostate Cancer Drugs Market by Company

Takeda Pharmaceuticals

Teva Pharmaceutical

Sanofi

Johnson & Johnson

Novartis

Merck Group

GlaxoSmithKline

Amgen

AbbVie

Tokai Pharmaceuticals

Spectrum Pharmaceuticals

Northwest Biotherapeutics

Janssen Pharmaceuticals

Foresee Pharmaceuticals

Ferring Pharmaceutical

Endo Pharmaceuticals

Boehringer Ingelheim

BMS

Bayer HealthCare

Astra Zeneca

Astellas Pharma

Prostate Cancer Drugs Segment by Type

Targeted Therapy

Chemotherapy

Hormonal Therapy

Immunotherapy

Prostate Cancer Drugs Segment by Application

Clinics

Hospitals

Others

Prostate Cancer Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prostate Cancer Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prostate Cancer Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prostate Cancer Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Prostate Cancer Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Prostate Cancer Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Targeted Therapy Table 2. Major Company of Chemotherapy Table 3. Major Company of Hormonal Therapy Table 4. Major Company of Immunotherapy Table 5. Global Prostate Cancer Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Prostate Cancer Drugs Sales by Type (2021-2026) & (K Tons) Table 7. Global Prostate Cancer Drugs Sales Market Share in Volume by Type (2021-2026) Table 8. Global Prostate Cancer Drugs Sales by Type (2021-2026) & (US$ Million) Table 9. Global Prostate Cancer Drugs Sales Market Share in Value by Type (2021-2026) Table 10. Global Prostate Cancer Drugs Price by Type (2021-2026) & (US$/Ton) Table 11. Global Prostate Cancer Drugs Sales by Type (2027-2032) & (K Tons) Table 12. Global Prostate Cancer Drugs Sales Market Share in Volume by Type (2027-2032) Table 13. Global Prostate Cancer Drugs Sales by Type (2027-2032) & (US$ Million) Table 14. Global Prostate Cancer Drugs Sales Market Share in Value by Type (2027-2032) Table 15. Global Prostate Cancer Drugs Price by Type (2027-2032) & (US$/Ton) Table 16. North America Prostate Cancer Drugs Sales by Type (2021-2026) & (K Tons) Table 17. North America Prostate Cancer Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Prostate Cancer Drugs Sales by Type (2021-2026) & (K Tons) Table 19. Europe Prostate Cancer Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Prostate Cancer Drugs Sales by Type (2021-2026) & (K Tons) Table 21. Asia-Pacific Prostate Cancer Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Prostate Cancer Drugs Sales by Type (2021-2026) & (K Tons) Table 23. Latin America Prostate Cancer Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Prostate Cancer Drugs Sales by Type (2021-2026) & (K Tons) Table 25. Middle East and Africa Prostate Cancer Drugs Sales by Type (2021-2026) & (US$ Million) Table 26. Prostate Cancer Drugs Industry Trends Table 27. Prostate Cancer Drugs Industry Drivers Table 28. Prostate Cancer Drugs Industry Opportunities and Challenges Table 29. Prostate Cancer Drugs Industry Restraints Table 30. Global Prostate Cancer Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Prostate Cancer Drugs Revenue Market Share by Company (2021-2026) Table 32. Global Prostate Cancer Drugs Sales by Company (2021-2026) & (K Tons) Table 33. Global Prostate Cancer Drugs Sales Share by Company (2021-2026) Table 34. Global Prostate Cancer Drugs Market Price by Company (2021-2026) & (US$/Ton) Table 35. Global Prostate Cancer Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Prostate Cancer Drugs Major Company Production Sites and Headquarters Table 37. Global Prostate Cancer Drugs Company, Product Type & Application Table 38. Global Prostate Cancer Drugs Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Prostate Cancer Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Prostate Cancer Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Prostate Cancer Drugs Sales by Region (2021-2026) & (K Tons) Table 43. Global Prostate Cancer Drugs Sales Market Share in Volume by Region (2021-2026) Table 44. Global Prostate Cancer Drugs Sales by Region (2021-2026) & (US$ Million) Table 45. Global Prostate Cancer Drugs Sales Market Share in Value by Region (2021-2026) Table 46. Global Prostate Cancer Drugs Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 47. Global Prostate Cancer Drugs Sales by Region (2027-2032) & (K Tons) Table 48. Global Prostate Cancer Drugs Sales Market Share in Volume by Region (2027-2032) Table 49. Global Prostate Cancer Drugs Sales by Region (2027-2032) & (US$ Million) Table 50. Global Prostate Cancer Drugs Sales Market Share in Value by Region (2027-2032) Table 51. Global Prostate Cancer Drugs Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 52. Global Prostate Cancer Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Prostate Cancer Drugs Sales by Application (2021-2026) & (K Tons) Table 54. Global Prostate Cancer Drugs Sales Market Share in Volume by Application (2021-2026) Table 55. Global Prostate Cancer Drugs Sales by Application (2021-2026) & (US$ Million) Table 56. Global Prostate Cancer Drugs Sales Market Share in Value by Application (2021-2026) Table 57. Global Prostate Cancer Drugs Price by Application (2021-2026) & (US$/Ton) Table 58. Global Prostate Cancer Drugs Sales by Application (2027-2032) & (K Tons) Table 59. Global Prostate Cancer Drugs Sales Market Share in Volume by Application (2027-2032) Table 60. Global Prostate Cancer Drugs Sales by Application (2027-2032) & (US$ Million) Table 61. Global Prostate Cancer Drugs Sales Market Share in Value by Application (2027-2032) Table 62. Global Prostate Cancer Drugs Price by Application (2027-2032) & (US$/Ton) Table 63. North America Prostate Cancer Drugs Sales by Application (2021-2026) & (K Tons) Table 64. North America Prostate Cancer Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Prostate Cancer Drugs Sales by Application (2021-2026) & (K Tons) Table 66. Europe Prostate Cancer Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Prostate Cancer Drugs Sales by Application (2021-2026) & (K Tons) Table 68. Asia-Pacific Prostate Cancer Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Prostate Cancer Drugs Sales by Application (2021-2026) & (K Tons) Table 70. Latin America Prostate Cancer Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Prostate Cancer Drugs Sales by Application (2021-2026) & (K Tons) Table 72. Middle East and Africa Prostate Cancer Drugs Sales by Application (2021-2026) & (US$ Million) Table 73. Takeda Pharmaceuticals Company Information Table 74. Takeda Pharmaceuticals Business Overview Table 75. Takeda Pharmaceuticals Prostate Cancer Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 76. Takeda Pharmaceuticals Prostate Cancer Drugs Product Portfolio Table 77. Takeda Pharmaceuticals Recent Development Table 78. Teva Pharmaceutical Company Information Table 79. Teva Pharmaceutical Business Overview Table 80. Teva Pharmaceutical Prostate Cancer Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 81. Teva Pharmaceutical Prostate Cancer Drugs Product Portfolio Table 82. Teva Pharmaceutical Recent Development Table 83. Sanofi Company Information Table 84. Sanofi Business Overview Table 85. Sanofi Prostate Cancer Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 86. Sanofi Prostate Cancer Drugs Product Portfolio Table 87. Sanofi Recent Development Table 88. Johnson & Johnson Company Information Table 89. Johnson & Johnson Business Overview Table 90. Johnson & Johnson Prostate Cancer Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 91. Johnson & Johnson Prostate Cancer Drugs Product Portfolio Table 92. Johnson & Johnson Recent Development Table 93. Novartis Company Information Table 94. Novartis Business Overview Table 95. Novartis Prostate Cancer Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 96. Novartis Prostate Cancer Drugs Product Portfolio Table 97. Novartis Recent Development Table 98. Merck Group Company Information Table 99. Merck Group Business Overview Table 100. Merck Group Prostate Cancer Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 101. Merck Group Prostate Cancer Drugs Product Portfolio Table 102. Merck Group Recent Development Table 103. GlaxoSmithKline Company Information Table 104. GlaxoSmithKline Business Overview Table 105. GlaxoSmithKline Prostate Cancer Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 106. GlaxoSmithKline Prostate Cancer Drugs Product Portfolio Table 107. GlaxoSmithKline Recent Development Table 108. Amgen Company Information Table 109. Amgen Business Overview Table 110. Amgen Prostate Cancer Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 111. Amgen Prostate Cancer Drugs Product Portfolio Table 112. Amgen Recent Development Table 113. AbbVie Company Information Table 114. AbbVie Business Overview Table 115. AbbVie Prostate Cancer Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 116. AbbVie Prostate Cancer Drugs Product Portfolio Table 117. AbbVie Recent Development Table 118. Tokai Pharmaceuticals Company Information Table 119. Tokai Pharmaceuticals Business Overview Table 120. Tokai Pharmaceuticals Prostate Cancer Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 121. Tokai Pharmaceuticals Prostate Cancer Drugs Product Portfolio Table 122. Tokai Pharmaceuticals Recent Development Table 123. Spectrum Pharmaceuticals Company Information Table 124. Spectrum Pharmaceuticals Business Overview Table 125. Spectrum Pharmaceuticals Prostate Cancer Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 126. Spectrum Pharmaceuticals Prostate Cancer Drugs Product Portfolio Table 127. Spectrum Pharmaceuticals Recent Development Table 128. Northwest Biotherapeutics Company Information Table 129. Northwest Biotherapeutics Business Overview Table 130. Northwest Biotherapeutics Prostate Cancer Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 131. Northwest Biotherapeutics Prostate Cancer Drugs Product Portfolio Table 132. Northwest Biotherapeutics Recent Development Table 133. Janssen Pharmaceuticals Company Information Table 134. Janssen Pharmaceuticals Business Overview Table 135. Janssen Pharmaceuticals Prostate Cancer Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 136. Janssen Pharmaceuticals Prostate Cancer Drugs Product Portfolio Table 137. Janssen Pharmaceuticals Recent Development Table 138. Foresee Pharmaceuticals Company Information Table 139. Foresee Pharmaceuticals Business Overview Table 140. Foresee Pharmaceuticals Prostate Cancer Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 141. Foresee Pharmaceuticals Prostate Cancer Drugs Product Portfolio Table 142. Foresee Pharmaceuticals Recent Development Table 143. Ferring Pharmaceutical Company Information Table 144. Ferring Pharmaceutical Business Overview Table 145. Ferring Pharmaceutical Prostate Cancer Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 146. Ferring Pharmaceutical Prostate Cancer Drugs Product Portfolio Table 147. Ferring Pharmaceutical Recent Development Table 148. Endo Pharmaceuticals Company Information Table 149. Endo Pharmaceuticals Business Overview Table 150. Endo Pharmaceuticals Prostate Cancer Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 151. Endo Pharmaceuticals Prostate Cancer Drugs Product Portfolio Table 152. Endo Pharmaceuticals Recent Development Table 153. Boehringer Ingelheim Company Information Table 154. Boehringer Ingelheim Business Overview Table 155. Boehringer Ingelheim Prostate Cancer Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 156. Boehringer Ingelheim Prostate Cancer Drugs Product Portfolio Table 157. Boehringer Ingelheim Recent Development Table 158. BMS Company Information Table 159. BMS Business Overview Table 160. BMS Prostate Cancer Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 161. BMS Prostate Cancer Drugs Product Portfolio Table 162. BMS Recent Development Table 163. Bayer HealthCare Company Information Table 164. Bayer HealthCare Business Overview Table 165. Bayer HealthCare Prostate Cancer Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 166. Bayer HealthCare Prostate Cancer Drugs Product Portfolio Table 167. Bayer HealthCare Recent Development Table 168. Astra Zeneca Company Information Table 169. Astra Zeneca Business Overview Table 170. Astra Zeneca Prostate Cancer Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 171. Astra Zeneca Prostate Cancer Drugs Product Portfolio Table 172. Astra Zeneca Recent Development Table 173. Astellas Pharma Company Information Table 174. Astellas Pharma Business Overview Table 175. Astellas Pharma Prostate Cancer Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 176. Astellas Pharma Prostate Cancer Drugs Product Portfolio Table 177. Astellas Pharma Recent Development Table 178. North America Prostate Cancer Drugs Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 179. North America Prostate Cancer Drugs Sales by Country (2021-2026) & (K Tons) Table 180. North America Prostate Cancer Drugs Sales Market Share by Country (2021-2026) Table 181. North America Prostate Cancer Drugs Sales Forecast by Country (2027-2032) & (K Tons) Table 182. North America Prostate Cancer Drugs Sales Market Share Forecast by Country (2027-2032) Table 183. North America Prostate Cancer Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. North America Prostate Cancer Drugs Market Size by Country (2021-2026) & (US$ Million) Table 185. North America Prostate Cancer Drugs Market Share by Country (2021-2026) Table 186. North America Prostate Cancer Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. North America Prostate Cancer Drugs Market Share Forecast by Country (2027-2032) Table 188. Europe Prostate Cancer Drugs Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 189. Europe Prostate Cancer Drugs Sales by Country (2021-2026) & (K Tons) Table 190. Europe Prostate Cancer Drugs Sales Market Share by Country (2021-2026) Table 191. Europe Prostate Cancer Drugs Sales Forecast by Country (2027-2032) & (K Tons) Table 192. Europe Prostate Cancer Drugs Sales Market Share Forecast by Country (2027-2032) Table 193. Europe Prostate Cancer Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 194. Europe Prostate Cancer Drugs Market Size by Country (2021-2026) & (US$ Million) Table 195. Europe Prostate Cancer Drugs Market Share by Country (2021-2026) Table 196. Europe Prostate Cancer Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 197. Europe Prostate Cancer Drugs Market Share Forecast by Country (2027-2032) Table 198. Asia-Pacific Prostate Cancer Drugs Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 199. Asia-Pacific Prostate Cancer Drugs Sales by Country (2021-2026) & (K Tons) Table 200. Asia-Pacific Prostate Cancer Drugs Sales Market Share by Country (2021-2026) Table 201. Asia-Pacific Prostate Cancer Drugs Sales Forecast by Country (2027-2032) & (K Tons) Table 202. Asia-Pacific Prostate Cancer Drugs Sales Market Share Forecast by Country (2027-2032) Table 203. Asia-Pacific Prostate Cancer Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 204. Asia-Pacific Prostate Cancer Drugs Market Size by Country (2021-2026) & (US$ Million) Table 205. Asia-Pacific Prostate Cancer Drugs Market Share by Country (2021-2026) Table 206. Asia-Pacific Prostate Cancer Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 207. Asia-Pacific Prostate Cancer Drugs Market Share Forecast by Country (2027-2032) Table 208. Latin America Prostate Cancer Drugs Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 209. Latin America Prostate Cancer Drugs Sales by Country (2021-2026) & (K Tons) Table 210. Latin America Prostate Cancer Drugs Sales Market Share by Country (2021-2026) Table 211. Latin America Prostate Cancer Drugs Sales Forecast by Country (2027-2032) & (K Tons) Table 212. Latin America Prostate Cancer Drugs Sales Market Share Forecast by Country (2027-2032) Table 213. Latin America Prostate Cancer Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 214. Latin America Prostate Cancer Drugs Market Size by Country (2021-2026) & (US$ Million) Table 215. Latin America Prostate Cancer Drugs Market Share by Country (2021-2026) Table 216. Latin America Prostate Cancer Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 217. Latin America Prostate Cancer Drugs Market Share Forecast by Country (2027-2032) Table 218. Middle East and Africa Prostate Cancer Drugs Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 219. Middle East and Africa Prostate Cancer Drugs Sales by Country (2021-2026) & (K Tons) Table 220. Middle East and Africa Prostate Cancer Drugs Sales Market Share by Country (2021-2026) Table 221. Middle East and Africa Prostate Cancer Drugs Sales Forecast by Country (2027-2032) & (K Tons) Table 222. Middle East and Africa Prostate Cancer Drugs Sales Market Share Forecast by Country (2027-2032) Table 223. Middle East and Africa Prostate Cancer Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 224. Middle East and Africa Prostate Cancer Drugs Market Size by Country (2021-2026) & (US$ Million) Table 225. Middle East and Africa Prostate Cancer Drugs Market Share by Country (2021-2026) Table 226. Middle East and Africa Prostate Cancer Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 227. Middle East and Africa Prostate Cancer Drugs Market Share Forecast by Country (2027-2032) Table 228. Key Raw Materials Table 229. Raw Materials Key Suppliers Table 230. Prostate Cancer Drugs Distributors List Table 231. Prostate Cancer Drugs Customers List Table 232. Research Programs/Design for This Report Table 233. Authors List of This Report Table 234. Secondary Sources Table 235. Primary Sources List of Figures Figure 1. Prostate Cancer Drugs Image Figure 2. Global Prostate Cancer Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prostate Cancer Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Prostate Cancer Drugs Sales (2021-2032) & (K Tons) Figure 5. Targeted Therapy Image Figure 6. Global Targeted Therapy Sales YoY Growth (2021-2032) & (K Tons) Figure 7. Chemotherapy Image Figure 8. Global Chemotherapy Sales YoY Growth (2021-2032) & (K Tons) Figure 9. Hormonal Therapy Image Figure 10. Global Hormonal Therapy Sales YoY Growth (2021-2032) & (K Tons) Figure 11. Immunotherapy Image Figure 12. Global Immunotherapy Sales YoY Growth (2021-2032) & (K Tons) Figure 13. Global Prostate Cancer Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Prostate Cancer Drugs Market Share by Type 2025 VS 2032 Figure 15. North America Prostate Cancer Drugs Sales Market Share in Volume by Type in 2025 Figure 16. North America Prostate Cancer Drugs Sales Market Share in Value by Type in 2025 Figure 17. Europe Prostate Cancer Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Europe Prostate Cancer Drugs Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Prostate Cancer Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Prostate Cancer Drugs Sales Market Share in Value by Type in 2025 Figure 21. Latin America Prostate Cancer Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Prostate Cancer Drugs Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Prostate Cancer Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Prostate Cancer Drugs Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Prostate Cancer Drugs Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Clinics Image Figure 28. Global Clinics Sales YoY Growth (2021-2032) & (K Tons) Figure 29. Hospitals Image Figure 30. Global Hospitals Sales YoY Growth (2021-2032) & (K Tons) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (K Tons) Figure 33. Global Prostate Cancer Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Prostate Cancer Drugs Market Share by Application 2025 VS 2032 Figure 35. North America Prostate Cancer Drugs Sales Market Share in Volume by Application in 2025 Figure 36. North America Prostate Cancer Drugs Sales Market Share in Value by Application in 2025 Figure 37. Europe Prostate Cancer Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Europe Prostate Cancer Drugs Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Prostate Cancer Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Prostate Cancer Drugs Sales Market Share in Value by Application in 2025 Figure 41. Latin America Prostate Cancer Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Prostate Cancer Drugs Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Prostate Cancer Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Prostate Cancer Drugs Sales Market Share in Value by Application in 2025 Figure 45. North America Prostate Cancer Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 46. North America Prostate Cancer Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Prostate Cancer Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Prostate Cancer Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Prostate Cancer Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 50. Europe Prostate Cancer Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Prostate Cancer Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Prostate Cancer Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Prostate Cancer Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 54. Asia-Pacific Prostate Cancer Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Prostate Cancer Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Prostate Cancer Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Prostate Cancer Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 58. Latin America Prostate Cancer Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Prostate Cancer Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Prostate Cancer Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Prostate Cancer Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 62. Middle East and Africa Prostate Cancer Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Prostate Cancer Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Prostate Cancer Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Prostate Cancer Drugs Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Prostate Cancer Drugs Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Targeted Therapy
  • Chemotherapy
  • Hormonal Therapy
  • Immunotherapy
Applications
  • Clinics
  • Hospitals
  • Others
Companies covered
  • Takeda Pharmaceuticals
  • Teva Pharmaceutical
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Merck Group
  • GlaxoSmithKline
  • Amgen
  • AbbVie
  • Tokai Pharmaceuticals
  • Spectrum Pharmaceuticals
  • Northwest Biotherapeutics
  • Janssen Pharmaceuticals
  • Foresee Pharmaceuticals
  • Ferring Pharmaceutical
  • Endo Pharmaceuticals
  • Boehringer Ingelheim
  • BMS
  • Bayer HealthCare
  • Astra Zeneca
  • Astellas Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Prostate Cancer Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Prostate Cancer Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Prostate Cancer Drugs Market by Type
  6. 1.3.1 Targeted Therapy
  7. 1.3.2 Chemotherapy
  8. 1.3.3 Hormonal Therapy
  9. 1.3.4 Immunotherapy
  10. 1.4 Global Prostate Cancer Drugs Market Size by Type
  11. 1.4.1 Global Prostate Cancer Drugs Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Prostate Cancer Drugs Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Prostate Cancer Drugs Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Prostate Cancer Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Prostate Cancer Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Prostate Cancer Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Prostate Cancer Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Prostate Cancer Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Prostate Cancer Drugs Industry Trends
  2. 2.2 Prostate Cancer Drugs Industry Drivers
  3. 2.3 Prostate Cancer Drugs Industry Opportunities and Challenges
  4. 2.4 Prostate Cancer Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Prostate Cancer Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Prostate Cancer Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Prostate Cancer Drugs Price (2021-2026)
  4. 3.4 Global Prostate Cancer Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Prostate Cancer Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Prostate Cancer Drugs Company, Product Type & Application
  7. 3.7 Global Prostate Cancer Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Prostate Cancer Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Prostate Cancer Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Prostate Cancer Drugs Tier 1, Tier 2, and Tier 3
4 Prostate Cancer Drugs Regional Status and Outlook
  1. 4.1 Global Prostate Cancer Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Prostate Cancer Drugs Historic Market Size by Region
  3. 4.2.1 Global Prostate Cancer Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Prostate Cancer Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Prostate Cancer Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Prostate Cancer Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Prostate Cancer Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Prostate Cancer Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Prostate Cancer Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Prostate Cancer Drugs by Application
  1. 5.1 Prostate Cancer Drugs Market by Application
  2. 5.1.1 Clinics
  3. 5.1.2 Hospitals
  4. 5.1.3 Others
  5. 5.2 Global Prostate Cancer Drugs Market Size by Application
  6. 5.2.1 Global Prostate Cancer Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Prostate Cancer Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Prostate Cancer Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Prostate Cancer Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Prostate Cancer Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Prostate Cancer Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Prostate Cancer Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Prostate Cancer Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Takeda Pharmaceuticals
  2. 6.1.1 Takeda Pharmaceuticals Company Information
  3. 6.1.2 Takeda Pharmaceuticals Business Overview
  4. 6.1.3 Takeda Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Pharmaceuticals Prostate Cancer Drugs Product Portfolio
  6. 6.1.5 Takeda Pharmaceuticals Recent Developments
  7. 6.2 Teva Pharmaceutical
  8. 6.2.1 Teva Pharmaceutical Company Information
  9. 6.2.2 Teva Pharmaceutical Business Overview
  10. 6.2.3 Teva Pharmaceutical Prostate Cancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Teva Pharmaceutical Prostate Cancer Drugs Product Portfolio
  12. 6.2.5 Teva Pharmaceutical Recent Developments
  13. 6.3 Sanofi
  14. 6.3.1 Sanofi Company Information
  15. 6.3.2 Sanofi Business Overview
  16. 6.3.3 Sanofi Prostate Cancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sanofi Prostate Cancer Drugs Product Portfolio
  18. 6.3.5 Sanofi Recent Developments
  19. 6.4 Johnson & Johnson
  20. 6.4.1 Johnson & Johnson Company Information
  21. 6.4.2 Johnson & Johnson Business Overview
  22. 6.4.3 Johnson & Johnson Prostate Cancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Johnson & Johnson Prostate Cancer Drugs Product Portfolio
  24. 6.4.5 Johnson & Johnson Recent Developments
  25. 6.5 Novartis
  26. 6.5.1 Novartis Company Information
  27. 6.5.2 Novartis Business Overview
  28. 6.5.3 Novartis Prostate Cancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Novartis Prostate Cancer Drugs Product Portfolio
  30. 6.5.5 Novartis Recent Developments
  31. 6.6 Merck Group
  32. 6.6.1 Merck Group Company Information
  33. 6.6.2 Merck Group Business Overview
  34. 6.6.3 Merck Group Prostate Cancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Merck Group Prostate Cancer Drugs Product Portfolio
  36. 6.6.5 Merck Group Recent Developments
  37. 6.7 GlaxoSmithKline
  38. 6.7.1 GlaxoSmithKline Company Information
  39. 6.7.2 GlaxoSmithKline Business Overview
  40. 6.7.3 GlaxoSmithKline Prostate Cancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 GlaxoSmithKline Prostate Cancer Drugs Product Portfolio
  42. 6.7.5 GlaxoSmithKline Recent Developments
  43. 6.8 Amgen
  44. 6.8.1 Amgen Company Information
  45. 6.8.2 Amgen Business Overview
  46. 6.8.3 Amgen Prostate Cancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Amgen Prostate Cancer Drugs Product Portfolio
  48. 6.8.5 Amgen Recent Developments
  49. 6.9 AbbVie
  50. 6.9.1 AbbVie Company Information
  51. 6.9.2 AbbVie Business Overview
  52. 6.9.3 AbbVie Prostate Cancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 AbbVie Prostate Cancer Drugs Product Portfolio
  54. 6.9.5 AbbVie Recent Developments
  55. 6.10 Tokai Pharmaceuticals
  56. 6.10.1 Tokai Pharmaceuticals Company Information
  57. 6.10.2 Tokai Pharmaceuticals Business Overview
  58. 6.10.3 Tokai Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Tokai Pharmaceuticals Prostate Cancer Drugs Product Portfolio
  60. 6.10.5 Tokai Pharmaceuticals Recent Developments
  61. 6.11 Spectrum Pharmaceuticals
  62. 6.11.1 Spectrum Pharmaceuticals Company Information
  63. 6.11.2 Spectrum Pharmaceuticals Business Overview
  64. 6.11.3 Spectrum Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Spectrum Pharmaceuticals Prostate Cancer Drugs Product Portfolio
  66. 6.11.5 Spectrum Pharmaceuticals Recent Developments
  67. 6.12 Northwest Biotherapeutics
  68. 6.12.1 Northwest Biotherapeutics Company Information
  69. 6.12.2 Northwest Biotherapeutics Business Overview
  70. 6.12.3 Northwest Biotherapeutics Prostate Cancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Northwest Biotherapeutics Prostate Cancer Drugs Product Portfolio
  72. 6.12.5 Northwest Biotherapeutics Recent Developments
  73. 6.13 Janssen Pharmaceuticals
  74. 6.13.1 Janssen Pharmaceuticals Company Information
  75. 6.13.2 Janssen Pharmaceuticals Business Overview
  76. 6.13.3 Janssen Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Janssen Pharmaceuticals Prostate Cancer Drugs Product Portfolio
  78. 6.13.5 Janssen Pharmaceuticals Recent Developments
  79. 6.14 Foresee Pharmaceuticals
  80. 6.14.1 Foresee Pharmaceuticals Company Information
  81. 6.14.2 Foresee Pharmaceuticals Business Overview
  82. 6.14.3 Foresee Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Foresee Pharmaceuticals Prostate Cancer Drugs Product Portfolio
  84. 6.14.5 Foresee Pharmaceuticals Recent Developments
  85. 6.15 Ferring Pharmaceutical
  86. 6.15.1 Ferring Pharmaceutical Company Information
  87. 6.15.2 Ferring Pharmaceutical Business Overview
  88. 6.15.3 Ferring Pharmaceutical Prostate Cancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Ferring Pharmaceutical Prostate Cancer Drugs Product Portfolio
  90. 6.15.5 Ferring Pharmaceutical Recent Developments
  91. 6.16 Endo Pharmaceuticals
  92. 6.16.1 Endo Pharmaceuticals Company Information
  93. 6.16.2 Endo Pharmaceuticals Business Overview
  94. 6.16.3 Endo Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Endo Pharmaceuticals Prostate Cancer Drugs Product Portfolio
  96. 6.16.5 Endo Pharmaceuticals Recent Developments
  97. 6.17 Boehringer Ingelheim
  98. 6.17.1 Boehringer Ingelheim Company Information
  99. 6.17.2 Boehringer Ingelheim Business Overview
  100. 6.17.3 Boehringer Ingelheim Prostate Cancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Boehringer Ingelheim Prostate Cancer Drugs Product Portfolio
  102. 6.17.5 Boehringer Ingelheim Recent Developments
  103. 6.18 BMS
  104. 6.18.1 BMS Company Information
  105. 6.18.2 BMS Business Overview
  106. 6.18.3 BMS Prostate Cancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 BMS Prostate Cancer Drugs Product Portfolio
  108. 6.18.5 BMS Recent Developments
  109. 6.19 Bayer HealthCare
  110. 6.19.1 Bayer HealthCare Company Information
  111. 6.19.2 Bayer HealthCare Business Overview
  112. 6.19.3 Bayer HealthCare Prostate Cancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Bayer HealthCare Prostate Cancer Drugs Product Portfolio
  114. 6.19.5 Bayer HealthCare Recent Developments
  115. 6.20 Astra Zeneca
  116. 6.20.1 Astra Zeneca Company Information
  117. 6.20.2 Astra Zeneca Business Overview
  118. 6.20.3 Astra Zeneca Prostate Cancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Astra Zeneca Prostate Cancer Drugs Product Portfolio
  120. 6.20.5 Astra Zeneca Recent Developments
  121. 6.21 Astellas Pharma
  122. 6.21.1 Astellas Pharma Company Information
  123. 6.21.2 Astellas Pharma Business Overview
  124. 6.21.3 Astellas Pharma Prostate Cancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 Astellas Pharma Prostate Cancer Drugs Product Portfolio
  126. 6.21.5 Astellas Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Prostate Cancer Drugs Sales by Country
  2. 7.1.1 North America Prostate Cancer Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Prostate Cancer Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Prostate Cancer Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Prostate Cancer Drugs Market Size by Country
  6. 7.2.1 North America Prostate Cancer Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Prostate Cancer Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Prostate Cancer Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Prostate Cancer Drugs Sales by Country
  2. 8.1.1 Europe Prostate Cancer Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Prostate Cancer Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Prostate Cancer Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Prostate Cancer Drugs Market Size by Country
  6. 8.2.1 Europe Prostate Cancer Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Prostate Cancer Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Prostate Cancer Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Prostate Cancer Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Prostate Cancer Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Prostate Cancer Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Prostate Cancer Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Prostate Cancer Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Prostate Cancer Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Prostate Cancer Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Prostate Cancer Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Prostate Cancer Drugs Sales by Country
  2. 10.1.1 South America Prostate Cancer Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Prostate Cancer Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Prostate Cancer Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Prostate Cancer Drugs Market Size by Country
  6. 10.2.1 South America Prostate Cancer Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Prostate Cancer Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Prostate Cancer Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Prostate Cancer Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Prostate Cancer Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Prostate Cancer Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Prostate Cancer Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Prostate Cancer Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Prostate Cancer Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Prostate Cancer Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Prostate Cancer Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Prostate Cancer Drugs Value Chain Analysis
  2. 12.1.1 Prostate Cancer Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Prostate Cancer Drugs Production Mode & Process
  7. 12.2 Prostate Cancer Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Prostate Cancer Drugs Distributors
  10. 12.2.3 Prostate Cancer Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst